Since the public clinical trial registration system was launched twelve years ago in China, as the primary register of the WHO International Clinical Trial Registry, the Chinese Clinical Trial Registry (ChiCTR) has largely promoted the development of clinical trial registration in China, particularly in recent three years. The quantity of registered trials has increased rapidly and 3939 studies were registered in ChiCTR in 2017. An increasing number of investigators, Institutional Review Boarders and funding agencies were taking the trial registration into account in the medical research ethics issues these years. Considering the large number of workforce in public health, limited researchers knew clinical trial registration very well, even with misunderstandings. For instance most of them do not know the purpose of trial registration and the principle of local registration. A lot of Chinese medical journals editors have been working together with us to promote the development of clinical trial transparency in last ten years, and they have made outstanding contributions. We would like to appeal more medical journals to join the great revolution of medical research.
Citation： WU Taixiang, Minawaer ABUDU, HAO Yuan, KONG Xiangyu, CHEN Shuo, LI Youping. The past 10 years of clinical trial registration in China: status and challenge. Chinese Journal of Evidence-Based Medicine, 2018, 18(6): 522-525. doi: 10.7507/1672-2531.201801015 Copy